Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center

JY Lee, KM Kim, SG Lee, E Yu, YS Lim, HC Lee… - Journal of …, 2007 - Elsevier
BACKGROUND/AIMS: The aim of the study was to evaluate the prevalence and risk factors
of biopsy-proven non-alcoholic fatty liver disease (NAFLD) in potential living liver donors …

[HTML][HTML] Molecular targeted therapy for hepatocellular carcinoma: current and future

JW Shin, YH Chung - World journal of gastroenterology: WJG, 2013 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most frequent tumors worldwide. The majority
of HCC cases occur in patients with chronic liver disease. Despite regular surveillance to …

Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period

NH Park, YH Chung, HS Lee - Intervirology, 2010 - karger.com
Abstract Background: Hepatitis B virus (HBV) vaccination has effectively reduced the acute
and chronic infection rates in recent years. Since 1983, HBV vaccination has been …

Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein

IY Park, BH Sohn, E Yu, DJ Suh, YH Chung, JH Lee… - Gastroenterology, 2007 - Elsevier
Background & Aims: The involvement of the hepatitis B virus X (HBx) protein in epigenetic
modifications during hepatocarcinogenesis has not been previously characterized. The aim …

HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability

GA Kim, YS Lim, J An, D Lee, JH Shim, KM Kim… - Gut, 2014 - gut.bmj.com
Objective Little is known about the long-term clinical outcome and durability of HBsAg
seroclearance following nucleos (t) ide analogue (NUC) therapy in patients with chronic …

Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis

JH Shim, HC Lee, KM Kim, YS Lim, YH Chung… - Journal of …, 2010 - Elsevier
BACKGROUND & AIMS: The effect of entecavir (ETV) therapy on viral suppression and
hepatic function in hepatitis B virus (HBV) patients with decompensated cirrhosis has not …

Increased risk of adefovir resistance in patients with lamivudine‐resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy

YS Lee, DJ Suh, YS Lim, SW Jung, KM Kim… - …, 2006 - Wiley Online Library
Although adefovir dipivoxil (ADV) has a unique profile of delayed and infrequent resistance
in treatment‐naïve chronic hepatitis B patients, the association of ADV resistance with …

Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea

BC Song, DJ Suh, HC Lee, YH Chung, YS Lee - Hepatology, 2000 - journals.lww.com
It has been suggested that hepatitis B e antigen (HBeAg) seroconversion after lamivudine
therapy is durable in Caucasians with chronic hepatitis B (CHB). However, little is known …

Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes

SM Yoon, YS Lim, HJ Won, JH Kim, KM Kim… - International Journal of …, 2012 - Elsevier
PURPOSE: We have evaluated the clinical outcomes of patients after transarterial
chemoembolization (TACE) and 3-dimensional conformal radiotherapy for hepatocellular …

ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons

AP Joselin, SJ Hewitt, SM Callaghan… - Human molecular …, 2012 - academic.oup.com
Mutations in several genes, including Parkin, PTEN-induced kinase 1 (Pink1) and DJ-1, are
associated with rare inherited forms of Parkinson's disease (PD). Despite recent attention on …